Olivia Osborn

Company: Terns Pharmaceuticals

Job title: Senio Director

Seminars:

Enhanced Weight Loss and Metabolic Benefits from Combining THRβ and GLP-1R Agonism 12:30 pm

Exploring thyroid hormone receptor-beta (THRβ) agonist in combination with GLP-1R Examining the prevention of the metabolic adaptation that typically reduces energy expenditure during weight loss, resulting in greater overall weight loss and preservation of lean mass Detailing the preclinical findings that combination of TERN-501 plus GLP-1R agonism led to greater weight loss and increased fat…Read more

day: Conference Day One